LONDON (Alliance News) - Futura Medical PLC on Wednesday reported a widened annual loss widened as the company continued to focus on its lead erectile dysfunction treatment MED2005.Futura a Read More
LONDON (Alliance News) - Pharmaceutical firm Futura Medical PLC said Wednesday it has enrolled its first patient on a late-stage clinical trial of its MED2002 erectile dysfunction is a topical gel Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------London Stock a Read More
LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Friday after it said that it raised GBP5.6 million via a share placing, subscription and an open offer at a discounted company 80 7 Read More
LONDON (Alliance News) - Futura Medical PLC on Thursday said it is placing to raise no less than GBP5 million via an accelerated bookbuild and up to an additional GBP1 million through an open will Read More
LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Wednesday its interim loss deepened after revenue disappeared and costs rose, as it continued to make progress on the development 3 Read More
LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Wednesday after reporting that potential partners for the licensing of MED2002 have asked for further tests on the product before a Read More
LONDON (Alliance News) - European Wealth Group Ltd said Monday it appointed Jonathan Freeman as non-executive director.Freeman currently holds the roles of non-executive chairman of LED of Read More
LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.In Read More
LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Thursday it has started preparing for a phase III trial for its proposed erectile dysfunction gel MED 2002.This trial what a Read More
LONDON (Alliance News) - Futura Medical PLC said Wednesday that planned increase in research and development expenditure for the development of erectile dysfunction gel has in Read More
